Work

Hepatic Fat Reduction Due to Resmetirom in Patients With Nonalcoholic Steatohepatitis Is Associated With Improvement of Quality of Life

Year: 2021

Type: article

Source: Clinical Gastroenterology and Hepatology

DOI: 10.1016/j.cgh.2021.07.039

Authors: Zobair M. Younossi, Maria Stepanova, Rebecca A. Taub, Jordan Mark Barbone, Stephen A. Harrison

Institutions: Inova Health System, Inova Fairfax Hospital, Center for Outcomes Research in Liver Diseases, Madrigal Pharmaceuticals (United States), University of Oxford, Pinnacle Clinical Research

Language: English

Topic: Liver Disease Diagnosis and Treatment

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Bristol-Myers Squibb, Merck, Novartis, Gilead Sciences, AbbVie, Madrigal Pharmaceuticals, Shionogi

OpenAlex ID: W3184419739

FWCI: 8.817

Cites: 18

Cited by: 84

Related to: 10